The Toll-like receptors (TLRs) activated by conserved microbial or endogenous ?danger? molecules trigger intracellular signaling cascades, leading to inflammatory response that is essential for recovery from infection or sterile tissue damage. The excessive TLR response, however, is injurious to the host and can be fatal. The intracellular TLR signaling is initiated by recruitment of TLR adapters to activated TLRs through multiple, homotypic and heterotypic interactions of Toll-Interleukin-1 Receptor homology (TIR) domains present in all TLRs and TLR adapters. Protein interactions mediated by TIR domains, although critical for triggering of signaling, are not well understood due to several intrinsic properties that complicate the analysis of TIR interactions. These complicating factors are (i) the absence of a common TIR-TIR binding motif, (ii) the topological diversity of TIR interface positions, (iii) the ability of each TIR to establish multiple TIR-TIR interactions, (iv) the weakness of any binary TIR-TIR interaction, and (v) the highly cooperative nature of functional TIR-TIR interactions that lead to assembly of TLR signaling complexes. The longstanding goal of this proposal is to advance the molecular understanding of TIR-TIR recognition mechanisms and develop TLR targeted candidate therapeutics that abrogate signaling by blocking the intracellular protein interactions that are consequent to TLR activation. New study will focus on systemic analysis of TIR-TIR interactions that underlie TLR signaling and will decipher the atomic details for several TIR- TIR interactions critical for signal transduction. Specifically, in Aim 1, we will develop novel inhibitors of TLR5, TLR7, TLR8, and TLR9 and evaluate their potency in vivo.
Aim 2 is to define the molecular mechanisms of TIR antagonisms by decoy peptides. Studies of Sub-Aim 2.1 will employ the innovative fluorescence imaging approach, which we developed recently, to determine the TIR domains specifically targeted by particular inhibitors in cellular milieu. Sub-Aim 2.2 will employ fluorescence polarization assay (FP) and surface plasmon resonance analysis (SPR) to determine affinity and kinetics of peptide-TIR interactions in controlled environment using recombinant TIR domains. These cellular and in vitro studies will provide complementary and quantitative benchmarks for rapid evaluation of future optimized antagonists. In Sub-Aim 2.3 we will employ X-ray crystallography to decipher the atomic details of TIR-antagonist interactions.
Aim 3 is to optimize TIR-derived TLR antagonists using several rational and empirical approaches to increase their target-binding affinity and biological efficacy. The translational aspect of proposed research is the preclinical development of the in vivo potent TLR inhibitors, each with a defined mechanism of action, in several new specificity categories. Importantly, antagonists developed in this project target the intracellular signal transduction machinery. In that they are distinct from candidate therapeutics developed by other groups targeted to block the receptor-ligand interactions and thus our inhibitors may have different biological effects and a wider set of clinical indications.

Public Health Relevance

Toll-like receptor (TLR) signaling elicited by microbial molecules or endogenous ligands is crucial for the recovery from infection or healing of certain types of non-microbial tissue damage. However, if the TLR activation is excessive or emanates for too long, it can lead to inflammatory disease or even cause lethality in a severe case. This project will study early stages of generation of intracellular TLR signals, i.e., recruitment of adapter proteins to activated TLRs to develop pharmaceutically relevant inhibitors of these processes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI082299-08
Application #
9485834
Study Section
Innate Immunity and Inflammation Study Section (III)
Program Officer
Jiang, Chao
Project Start
2010-05-01
Project End
2021-05-31
Budget Start
2018-06-01
Budget End
2019-05-31
Support Year
8
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Maryland Baltimore
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
188435911
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Javmen, Artur; Szmacinski, Henryk; Lakowicz, Joseph R et al. (2018) Blocking TIR Domain Interactions in TLR9 Signaling. J Immunol 201:995-1006
Piao, Wenji; Ru, Lisa W; Toshchakov, Vladimir Y (2016) Differential adapter recruitment by TLR2 co-receptors. Pathog Dis 74:
Piao, Wenji; Shirey, Kari Ann; Ru, Lisa W et al. (2015) A Decoy Peptide that Disrupts TIRAP Recruitment to TLRs Is Protective in a Murine Model of Influenza. Cell Rep 11:1941-52
Szmacinski, Henryk; Toshchakov, Vladimir; Lakowicz, Joseph R (2014) Application of phasor plot and autofluorescence correction for study of heterogeneous cell population. J Biomed Opt 19:046017
Piao, Wenji; Vogel, Stefanie N; Toshchakov, Vladimir Y (2013) Inhibition of TLR4 signaling by TRAM-derived decoy peptides in vitro and in vivo. J Immunol 190:2263-72
Piao, Wenji; Ru, Lisa W; Piepenbrink, Kurt H et al. (2013) Recruitment of TLR adapter TRIF to TLR4 signaling complex is mediated by the second helical region of TRIF TIR domain. Proc Natl Acad Sci U S A 110:19036-41
Szmacinski, Henryk; Toshchakov, Vladimir; Piao, Wenji et al. (2013) Imaging of Protein Secretion from a Single Cell Using Plasmonic Substrates. Bionanoscience 3:30-36
Liu, Anguo; Gong, Ping; Hyun, Sang W et al. (2012) TRAF6 protein couples Toll-like receptor 4 signaling to Src family kinase activation and opening of paracellular pathway in human lung microvascular endothelia. J Biol Chem 287:16132-45
Couture, Leah A; Piao, Wenji; Ru, Lisa W et al. (2012) Targeting Toll-like receptor (TLR) signaling by Toll/interleukin-1 receptor (TIR) domain-containing adapter protein/MyD88 adapter-like (TIRAP/Mal)-derived decoy peptides. J Biol Chem 287:24641-8
Toshchakov, Vladimir Y; Szmacinski, Henryk; Couture, Leah A et al. (2011) Targeting TLR4 signaling by TLR4 Toll/IL-1 receptor domain-derived decoy peptides: identification of the TLR4 Toll/IL-1 receptor domain dimerization interface. J Immunol 186:4819-27